CytomX Therapeutics Inc. (CTMX) dropped -6.78% or -0.98 to $13.48. It is nearly 206891 shares traded, which is 47.98% compare to the average total volume 431170. The market cap of CTMX is $606.70 million. The year to date change is -40.32%. The 52 week price range is from $12.75 to $35.0. Price of CTMX have changed 4.63% during last week. It have changed -6.04% over last month, -35.90% over last 3 months, -41.15% over last 6 months and -29.36% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTMX is 16.45. It is 22.03% above current price. The 200-day Moving Averages for CTMX is 23.85. It is 76.93% above current price. The 52-week High is 35.0. It is 159.64% from the current price. The 52-week Low is 12.75. It is -5.42% from current price.
There are some statistics of CTMX. It is has market cap $606.70 million. The share outstanding is 45.01 million. The average volume is 431170. The percent of top 15 Institution holding is 128.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTMX is -50.95%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTMX is -11.90%.